Reproductive Health in Women with Major β-Thalassemia
Author Information
Author(s): Tsilionis Vasileios, Moustakli Efthalia, Dafopoulos Stefanos, Zikopoulos Athanasios, Sotiriou Sotirios, Zachariou Athanasios, Dafopoulos Konstantinos
Primary Institution: University of Thessaly
Hypothesis
How does β-thalassemia major affect ovarian reserve and endocrine complications in women?
Conclusion
Women with β-thalassemia major experience significant reproductive health challenges due to iron overload and oxidative stress, impacting their ovarian reserve and endocrine function.
Supporting Evidence
- Hypogonadotropic hypogonadism affects 40–91% of women with β-thalassemia major.
- Regular blood transfusions can lead to iron accumulation in the pituitary and hypothalamus.
- Anti-Müllerian hormone (AMH) is frequently used to assess ovarian damage in these patients.
- Effective disease management is the most reliable predictor of endocrine disorder risk.
- Oxidative stress from iron overload significantly impairs fertility.
Takeaway
Women with a blood condition called β-thalassemia major can have trouble having babies because of too much iron in their bodies, which can hurt their ovaries.
Methodology
This review explores the pathophysiology of β-thalassemia and its clinical manifestations, focusing on endocrine complications and ovarian reserve assessment.
Potential Biases
The findings may not be generalizable due to the small sample size and the heterogeneity of patient populations.
Limitations
The study highlights the challenges in monitoring iron levels and the variability in patient responses to treatments.
Participant Demographics
The study involved transfusion-dependent β-thalassemia patients, average age 16.9 years.
Statistical Information
P-Value
p<0.005
Confidence Interval
95% CI 6.3–13.1
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website